Expert Opinion on Emerging Drugs
Volume 17, 2012 - Issue 4
Open access
4,025
Views
118
CrossRef citations to date
0
Altmetric
Reviews
Liposomal amphotericin B as a treatment for human leishmaniasis
Manica BalasegaramDrugs for Neglected Diseases Initiative,
Geneva, Switzerland;Médecins Sans Frontières, Access Campaign,
Geneva, Switzerland
, Koert RitmeijerMédecins Sans Frontières, Operational Centre Amsterdam,
Amsterdam, The Netherlands
, Maria Angeles LimaMédecins Sans Frontières, Operational Centre Barcelona Athens,
Barcelona, Spain
, Sakib BurzaMédecins Sans Frontières, Operational Centre Barcelona Athens,
Barcelona, Spain
, Gemma Ortiz GenoveseMédecins Sans Frontières, Operational Centre Barcelona Athens,
Barcelona, Spain
, Barbara MilaniMédecins Sans Frontières, Access Campaign,
Paris, France
, Sara GaspaniMédecins Sans Frontières, Access Campaign,
Paris, France
, Julien PotetMédecins Sans Frontières, Access Campaign,
Paris, France
& François ChappuisMédecins Sans Frontières, Operational Centre Geneva,
Geneva, Switzerland;University of Geneva, andGeneva University Hospitals, Division of International and Humanitarian Medicine,
6, rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland+41 22 3729620; +41 22 3729626; [email protected]
show all
Pages 493-510
|
Published online: 20 Nov 2012
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.